About this trial
The aim of this study is to perform a comparative analysis of clinical outcomes associated with the use of an ultra-long peripheral catheter using (catheter-over-the-needle technique) versus an AST-long peripheral catheter in adult patients with difficult intravenous access (DIVA) in a real-world clinical setting. Specifically, the study will assess potential benefits, including longer mean catheter dwell time and improved catheter usability, as well as potential harms, such as increased incidence of catheter-related thrombosis, infections, phlebitis, infiltration, and unplanned catheter removal.
Eligibility criteria
Qualifiers
Adult inpatients with DIVA, requiring placement of a long peripheral catheter, will be included in the study.
A digital request form for venous access must be completed by the treating physician at the ward.
Patients must be proficient in either Dutch or French
Patients must have decision-making capacity or be represented by a legal representative.
Disqualifiers
Expected therapy duration of less than 24 hours
pregnancy
Need for central venous access
Inability to locate a deep peripheral vein in the upper extremity prior enrollment in the study
Trial design
Treatments tested in this trial
- Powerglide pro™
- Introcan safety deep access